STEVANATO GROUP SPA
(NYSE: STVN)
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.
19.590
+0.580
(+3.05%)
Range
18.995 - 20.270
(6.71%)
Open
19.050
Previous Close
19.010
Bid Price
19.000
Bid Volume
12
Ask Price
19.260
Ask Volume
10
Volume
488,679
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis